Sildenafil Teva Pharma

Medicinal product

(Invented) name

Sildenafil Teva Pharma

Active substance (s)

Sildenafilis

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BE03, Sildenafil

Marketing authorisation holder

Teva Pharma B.V., Nyderlandai

Date of authorisation

2016-12-08

Date of renewal

2021-03-05

Documents

4017 Pakuotės lapelis 2024 02 22.docx

4017 Sildenafil Teva Pharma II PL 2024 02 22.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

DE/H/4461/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Sildenafilis	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
64162	78610	1078610	lizdinė plokštelė	N30		Receptinis	LT/1/16/4017/001	Netiekiama	-	-	No	-	-
67264	81810	1081810	lizdinė plokštelė	N90		Receptinis	LT/1/16/4017/002	Tiekiama	-	-	No	-	-	Download
67265	81811	1081811	lizdinė plokštelė	N300		Receptinis	LT/1/16/4017/003	Netiekiama	-	-	No	-	-
67266	81812	1081812	dalomoji lizdinė plokštelė	N90x1		Receptinis	LT/1/16/4017/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-03-05	Perregistruotas
2016-12-08	Registruotas